Blog

Physiomics (LSE:PYC) reported a 26.5% increase in total income to a record £1.06 million for the financial year ended 30 June 2026, supported by its Modelling & Simulation business and initial revenue contributions from its newly established Biometrics division.

The AIM-listed mathematical modelling and biostatistics specialist said the annual income figure was its highest since inception. However, the company recorded an operating loss of £687,254, reflecting increased costs associated with corporate changes, fundraising activities and the use of external consultants.

Physiomics attributed part of the increase in expenditure to one-off costs arising from a shareholder requisition concerning the board, changes in senior leadership and a fundraising completed during the financial year.

Additional consultancy expenditure also contributed to the wider operating loss, while shareholders’ funds declined during the reporting period.

The company’s Modelling & Simulation activities continued to generate revenue from pharmaceutical and biotechnology customers, with projects covering multiple therapeutic areas.

Physiomics also recorded its first revenue from Biometrics, a service line established to expand the group’s offering beyond mathematical modelling into clinical data analysis and related statistical services.

The Biometrics business provides capabilities intended to support pharmaceutical research and clinical development programmes, complementing the company’s existing modelling and simulation operations.

During FY26, Physiomics secured 24 new contracts across several therapeutic areas, including projects involving drug development and clinical research.

The company ended the financial year with what it described as a record contract pipeline, alongside approximately £618,000 of contracted revenue that had not yet been recognised in its financial results.

This contracted but unrecognised revenue represents work secured by the company for which revenue recognition remains dependent on the delivery of services under the relevant agreements.

Physiomics also completed a £600,000 fundraising in March 2026 to provide additional capital for its operations and planned development activities.

The fundraising took place during a period of changes to the company’s board and management structure, including the departure of its long-serving chief executive officer.

New board appointments and senior operational hires were made during the year as the company expanded its management and technical resources.

Physiomics also introduced a quality management system intended to support its operational processes and the delivery of services to pharmaceutical and biotechnology customers.

The company has been investing in scientific and technical capabilities to support both its established Modelling & Simulation business and its newer Biometrics operations.

Another development during the year involved the integration of Physiomics’ personalised dosing software into the DoseMeRx platform.

The integration is intended to make the company’s dosing technology available through an established clinical software platform, supporting applications involving personalised treatment and dose optimisation.

Physiomics develops mathematical models and software designed to analyse biological and clinical data, with applications including drug development, treatment optimisation and clinical study design.

Its proprietary technologies include the Virtual Tumour platform, which is used in modelling work related to oncology drug development.

The company also provides services across other therapeutic areas, including immunology, infectious diseases and renal conditions.

Management is seeking to expand the range of projects undertaken by the business through its Biometrics offering, including work associated with later-stage clinical development programmes.

The company’s strategy includes combining modelling, data science and statistical analysis services to support customers across different stages of pharmaceutical research and development.

While total income increased during FY26, the wider operating loss reflected the impact of additional expenditure during the year, including costs associated with management changes and external consultancy support.

Physiomics enters the new financial year with approximately £618,000 of contracted but unrecognised revenue, an expanded service portfolio and additional management and technical resources.

The timing of future revenue recognition will depend on the delivery of contracted projects, while the financial contribution from the Biometrics division will depend on the development of its customer and contract base.

About Physiomics plc

Physiomics plc is a UK-based mathematical modelling, data science and biostatistics company providing specialist services to pharmaceutical and biotechnology businesses.

The company supports drug discovery, preclinical research and clinical development through mathematical modelling, simulation, biometrics, bioinformatics and statistical analysis.

Its Modelling & Simulation business uses computational methods to analyse biological and clinical information, including applications in oncology, immunology, infectious diseases and renal disease.

Physiomics’ proprietary technologies include its Virtual Tumour modelling platform and personalised dosing software designed to support treatment optimisation.

The company has worked with pharmaceutical and biotechnology organisations including Merck KGaA, Astellas, Bicycle Therapeutics, Numab Therapeutics and Cancer Research UK.

Through its Biometrics service line, Physiomics is expanding its capabilities in clinical data analysis and statistical services, alongside its existing modelling activities.

The group’s services are intended to support pharmaceutical companies in evaluating drug candidates, designing studies and analysing data throughout the development process.

Haydale (LSE:HAYD) reported revenue of approximately £5.0 million for the financial year ended 2026, below management’s previous expectations, as operational capacity constraints and delays in product deployment affected performance.

The AIM-listed advanced materials and clean technology company also reported an adjusted EBITDA loss of approximately £2.69 million, larger than previously anticipated, although gross margins improved to around 44% during the period.

Haydale attributed the revenue shortfall primarily to limitations in its ability to deliver projects through its SaveMoneyCutCarbon (SMCC) business, alongside delays in increasing deployment of its JustHeat product.

According to the company, demand for SaveMoneyCutCarbon’s services exceeded the delivery capacity available during the financial year, restricting the volume of projects that could be completed and recognised as revenue.

The company said the shortfall reflected operational delivery constraints rather than a reduction in customer demand or deterioration in the economics of individual projects.

Despite the lower-than-expected revenue and increased adjusted EBITDA loss, Haydale ended FY26 with cash balances ahead of management’s expectations. The supplied update did not disclose the year-end cash figure.

Gross margins of approximately 44% reflected an improvement in the proportion of revenue retained after direct costs, although the increase was insufficient to offset the impact of lower revenue on the group’s adjusted operating performance.

In response to the operational constraints, Haydale is changing the delivery structure of SaveMoneyCutCarbon, moving towards a model that relies more extensively on external installation and service partners.

The revised approach includes a new joint venture with Quidos Protect, which will provide access to an established nationwide supply chain for energy efficiency and clean technology installations.

Under the proposed structure, SaveMoneyCutCarbon will focus on customer relationships, project origination, programme management and consultancy services, while the joint venture will support the delivery of installation work through its partner network.

The delivery arrangements will cover solar energy systems, battery storage, electric vehicle charging infrastructure and other energy efficiency measures.

Haydale expects the new model to reduce the amount of fixed operational infrastructure required to support project delivery, allowing the business to use external capacity rather than expanding its own installation resources at the same rate as customer activity.

The company estimates that the annualised revenue required to reach operating breakeven will fall from approximately £17 million under its previous structure to around £10 million following implementation of the revised model.

This represents a reduction of approximately £7 million, or 41%, in the annualised revenue threshold needed to cover operating costs.

Management continues to target operating breakeven for the group’s current trading business during the first half of FY27.

The target remains dependent on the implementation of the revised delivery arrangements, the conversion of customer demand into completed projects and the resulting revenue and cost performance.

SaveMoneyCutCarbon provides energy and water efficiency services to commercial customers, including businesses and property-sector organisations seeking to implement energy-saving technologies and infrastructure improvements.

Its activities include consultancy, project planning, programme management and the supply of technologies intended to reduce energy and water consumption.

The company has been developing relationships with commercial partners to generate projects and expand its delivery network across the United Kingdom.

The joint venture with Quidos Protect is intended to address the installation capacity limitations identified during FY26 while allowing SaveMoneyCutCarbon to concentrate on project development and customer management.

Haydale expects the revised structure to reduce the working capital and fixed-cost requirements associated with delivering projects directly, although the financial impact will depend on operational performance following implementation.

The company is also continuing work on its JustHeat product following the delays experienced during FY26, which contributed to the difference between reported revenue and earlier expectations.

Haydale’s near-term priorities include implementing the new national delivery model, progressing its existing commercial pipeline and working towards its H1 FY27 operating breakeven target.

About Haydale plc

Haydale plc is an AIM-listed advanced materials and clean technology group with activities focused on energy efficiency, water efficiency and related technologies.

The company operates through its SaveMoneyCutCarbon business, which provides consultancy, technology procurement and project management services to commercial and property-sector customers.

SaveMoneyCutCarbon supports the development and implementation of energy and water efficiency projects, including solar installations, battery storage, electric vehicle charging systems and building retrofit measures.

Its commercial activities include project origination, programme design, customer advisory services and the coordination of installation and delivery partners.

Haydale is transitioning SaveMoneyCutCarbon towards a national delivery model supported by external installation providers, including its joint venture arrangements with Quidos Protect.

The company aims to expand its project delivery capabilities while reducing the fixed infrastructure required to support additional customer contracts.

Tap Global Group plc (LSE:TAP) has expanded its Digital Asset Income Strategy (DAIS) with the acquisition of 50 Ethereum (ETH) tokens, marking the company’s first investment in the cryptocurrency as part of its treasury management programme.

The crypto-fintech company purchased the tokens at an average price of £1,888.76 each, representing a total investment of approximately £94,438.

According to Tap Global, the acquisition price was around 50% below Ethereum’s previous all-time high, reflecting the market price at which the transaction was completed.

The newly acquired Ethereum has been allocated to Tap Earn, the group’s digital asset yield programme, which was launched in May 2026.

The purchase expands Tap Global’s DAIS reserve to three cryptocurrencies, comprising Bitcoin, Solana and Ethereum, alongside stablecoin holdings used within the programme.

The company said the reserve is maintained separately from funds used for its day-to-day operations, distinguishing its treasury investments from operational capital.

Under the DAIS framework, Tap Global allocates selected digital assets to income-generating activities through Tap Earn rather than holding them exclusively as non-yielding treasury assets.

The strategy is intended to generate returns from the company’s cryptocurrency holdings while maintaining exposure to the underlying digital assets.

Tap Global also provided an operational update on Tap Earn, reporting that customer assets held through the programme have exceeded US$9 million.

Since its launch in May 2026, Tap Earn has generated approximately US$157,000 in gross yield, according to the company.

The reported yield represents income generated through the programme before any applicable deductions or other adjustments. The supplied update did not provide a breakdown of the yield attributable to individual cryptocurrencies or distinguish the contributions from customer assets and company-held reserves.

Tap Earn forms part of the group’s wider cryptocurrency services, allowing eligible users to allocate supported digital assets to yield-generating arrangements.

The company is also using the platform to manage its own digital asset reserve, creating a treasury strategy that operates alongside its customer-facing services.

Management said the DAIS programme is designed to generate income from assets held on the company’s balance sheet, with the Ethereum purchase extending the range of cryptocurrencies included in the reserve.

The strategy differs from a passive cryptocurrency holding approach because selected assets are deployed through arrangements intended to produce yield.

However, cryptocurrency holdings remain exposed to market price fluctuations, while yield-generating arrangements can involve additional risks associated with counterparties, liquidity and the mechanisms used to generate returns.

The value of the company’s digital asset reserve may therefore change independently of any income generated through Tap Earn.

Tap Global has not provided a target return for the newly acquired Ethereum holdings or a timetable for additional purchases in the supplied announcement.

The latest acquisition follows the company’s existing allocations to Bitcoin and Solana as it continues implementing its Digital Asset Income Strategy.

With more than US$9 million in customer assets held through Tap Earn, the group is operating the programme for both customer participation and its own treasury holdings.

The company continues to develop its cryptocurrency trading, payments and digital asset services while maintaining separate arrangements for its operational funds and DAIS reserve.

About Tap Global Group plc

Tap Global Group plc is a London-listed cryptocurrency financial technology company providing digital asset trading, payments and related financial services through its Tap platform.

The company serves more than 400,000 customers across over 25 countries, offering access to more than 70 cryptocurrencies through its mobile application.

Its services include cryptocurrency trading, digital asset management, payment functionality and access to yield-generating products through Tap Earn.

The Tap platform also enables customers to make payments at merchants accepting Mastercard, providing a connection between digital asset holdings and everyday transactions.

Tap Global operates under Gibraltar’s Distributed Ledger Technology (DLT) regulatory framework and has outlined plans to seek cryptoasset authorisation in the United Kingdom.

The group’s Digital Asset Income Strategy involves holding selected cryptocurrencies and deploying them through its Tap Earn programme, with company-owned reserves maintained separately from operational funds.

Its activities span cryptocurrency trading, digital payments and digital asset yield services for retail customers.

EnergyPathways plc (LSE:EPP) has raised £1.75 million through a share placing with a single institutional investor to support the development of its MESH long-duration energy storage project and provide additional working capital.

The UK energy transition company issued the new shares at 5.75 pence each, with the proceeds intended to fund further project development activities, including the potential acquisition of land, pipelines and technical data associated with MESH.

The placing involves the issue of 30,434,782 new ordinary shares, which are expected to be admitted to trading on AIM on 15 October 2026.

Following admission, EnergyPathways will have 282,134,998 ordinary shares in issue, with the newly issued shares representing approximately 10.8% of the enlarged share capital.

The company also confirmed the closure of its Capital Access Window following completion of the fundraising process. Trading in its existing ordinary shares is scheduled to resume on 13 October 2026.

EnergyPathways said the additional funding will allow it to progress work on MESH, a proposed integrated energy storage development designed to combine compressed air, natural gas and hydrogen storage infrastructure.

The company intends to use part of the proceeds to acquire assets and technical information considered necessary for advancing the project through its development stages.

These acquisitions are intended to reduce project development risks and support future discussions with institutional investors and strategic partners regarding potential financing arrangements.

MESH has been designated as a project of national significance by the UK Government, according to the company.

The proposed development is designed to store surplus electricity generated by wind farms and make energy available when required, using a combination of long-duration storage technologies and associated gas infrastructure.

EnergyPathways is targeting a power capacity of approximately 300 megawatts and an energy storage capacity of 55 gigawatt-hours, with the proposed system designed to provide more than 100 hours of storage.

The company believes the project could contribute to reducing the amount of wind-generated electricity that is curtailed when supply exceeds demand or transmission capacity.

Management also expects the proposed infrastructure to provide additional flexibility to the UK electricity system by enabling stored energy to be dispatched during periods of lower renewable generation.

The project includes plans for natural gas and hydrogen storage facilities, alongside infrastructure intended to support future hydrogen production and energy supply.

EnergyPathways has indicated that hydrogen production could begin around 2029 to 2030, with long-duration energy storage operations potentially commencing during 2031 to 2032.

These timelines remain subject to the completion of development activities, regulatory approvals, government policy arrangements and the availability of project financing.

The company has also outlined the potential for MESH to provide gas storage capacity equivalent to approximately six days of UK national demand.

According to EnergyPathways, the proposed capacity could more than double the UK’s existing gas storage capability, although this remains dependent on the project’s development and eventual implementation.

The company considers the project a potential contributor to UK energy security through additional gas storage capacity and greater flexibility in balancing renewable electricity generation with demand.

The latest fundraising provides capital for the next phase of project development rather than full construction financing, with EnergyPathways continuing to pursue institutional and strategic investment opportunities.

The company will now focus on progressing asset acquisitions, technical work and other development requirements associated with MESH as it prepares for subsequent project stages.

About EnergyPathways plc

EnergyPathways plc is a UK-listed energy transition company focused on developing long-duration energy storage infrastructure and associated natural gas and hydrogen projects.

Its principal development is MESH, an integrated energy storage project intended to combine compressed air energy storage with natural gas and hydrogen infrastructure.

The project is designed to support electricity system flexibility by storing surplus renewable energy and providing dispatchable power during periods when generation from renewable sources is lower.

EnergyPathways is targeting a proposed capacity of 300 MW and 55 GWh, with more than 100 hours of energy storage capability.

The company’s development plans also include hydrogen production and gas storage infrastructure, with future operations dependent on technical development, regulatory approvals and financing.

EnergyPathways is pursuing a phased development strategy involving asset acquisition, engineering studies and engagement with potential institutional and strategic partners.

Kodal Minerals (LSE:KOD) reported production of 27,234 dry metric tonnes of spodumene concentrate at its Bougouni Lithium Project in Mali during the quarter ended 30 September 2026, bringing year-to-date output to 80,429 tonnes.

The AIM-listed mining company said concentrate produced during the quarter averaged 5.29% lithium oxide (Li2O), while maintaining its full-year production guidance of between 105,000 and 115,000 tonnes.

Kodal also reiterated its expected unit production cost range of US$600 to US$610, as operations continued at the project’s Stage 1 dense media separation (DMS) processing facility.

During the reporting period, the project completed its fourth and fifth export shipments through the port of San Pedro in Côte d’Ivoire, which serves as the export route for spodumene concentrate produced at Bougouni.

The fourth shipment generated approximately US$47 million in revenue, bringing total revenue from the first four shipments to around US$142.8 million.

The company also confirmed that the project’s operating vehicle had fully repaid an external loan provided by Hainan Mining, using cash generated from operations.

The repayment removes the outstanding obligation associated with that loan, following the commencement of commercial concentrate production and export shipments from Bougouni.

Mining activities at the Ngoualana open pit were affected during the quarter by seasonal rainfall and equipment availability, resulting in reduced mining volumes and a lower grade of ore supplied to the processing plant.

Kodal said these conditions affected the availability and quality of feed material, although the processing facility continued operating during the period.

To address the mining constraints, additional equipment and a new mining contractor have been mobilised to support ore extraction and transportation.

The measures are intended to improve the consistency of ore deliveries to the processing plant and maintain sufficient stockpiles to support ongoing production.

The company reported continued recovery performance at the DMS facility, although specific recovery rates were not provided in the supplied update.

Kodal also recorded no lost-time injuries or medically treated incidents during the quarter.

Alongside Stage 1 production, the company is progressing technical studies for a proposed Stage 2 flotation expansion at Bougouni.

The development work includes feasibility assessments, environmental studies and metallurgical testing to evaluate the proposed expansion and its processing requirements.

The Stage 2 project is intended to increase Bougouni’s production capacity beyond the existing DMS operation, although the supplied update did not specify a revised production target or development timetable.

Bougouni is operated through a partnership involving Kodal Mining UK, Hainan Mining and the Government of Mali. Kodal Minerals holds an ultimate economic interest of approximately 32% in the project.

The partnership structure provides Kodal with exposure to lithium production and associated cash flows while the operating entity manages mining, processing and export activities.

The company’s current operational priorities include maintaining production at the Stage 1 facility, addressing mining equipment and ore supply constraints, and advancing the technical work required for the proposed expansion.

With 80,429 tonnes of concentrate produced year to date, Kodal has maintained its annual production guidance of 105,000 to 115,000 tonnes, subject to operational performance during the remainder of the financial year.

The company continues to develop Bougouni as a lithium concentrate production operation, with further expansion dependent on the outcome of its ongoing technical and environmental assessments.

About Kodal Minerals

Kodal Minerals is an AIM-listed mining and mineral exploration company focused on lithium production and resource development in West Africa.

Its principal asset is the Bougouni Lithium Project in Mali, where spodumene concentrate is produced through a Stage 1 dense media separation processing facility.

The project is operated through a partnership involving Kodal Mining UK, Hainan Mining and the Government of Mali, with Kodal holding an ultimate economic interest of approximately 32%.

Bougouni produces spodumene concentrate for export, using transport infrastructure connecting the project to the port of San Pedro in Côte d’Ivoire.

The company is also evaluating a Stage 2 flotation processing expansion, with feasibility, metallurgical and environmental studies forming part of the proposed development programme.

Kodal’s activities include lithium mining, processing, mineral exploration and project development, with its operations focused on supplying raw materials used in the battery manufacturing sector.

Plus500 (LSE:PLUS) has conditionally agreed to acquire Hedge Capital Markets Inc., a US broker-dealer registered with the Securities and Exchange Commission (SEC) and a member of the Financial Industry Regulatory Authority (FINRA), as part of its expansion into the US securities trading market.

The proposed all-cash acquisition will provide Plus500 with access to the SEC-regulated securities segment, complementing its existing US operations in futures and prediction markets, which operate under Commodity Futures Trading Commission (CFTC) regulation.

Founded in 2021, Hedge Capital Markets provides brokerage services focused on US retail investors trading equities and exchange-traded funds (ETFs). The acquisition is intended to add securities trading capabilities to Plus500’s existing US product offering.

The transaction remains conditional, and financial terms were not disclosed in the supplied announcement.

Plus500 said the acquisition will be funded from its existing cash resources. The group reported cash reserves exceeding $860 million as of 30 June 2026, providing the funding source for the proposed purchase.

Alongside the acquisition, Plus500 is establishing a new operational hub in New York to support its US expansion. The office will complement the group’s existing Chicago operations, which serve its futures and other regulated trading activities.

The company intends to combine Hedge’s securities brokerage capabilities and regulatory registrations with its proprietary trading technology to develop an integrated multi-asset platform for US customers.

Plus500 is targeting the first quarter of 2027 for the launch of the new platform, which it describes as a trading super-app.

The proposed service is intended to provide access to multiple asset classes through a single platform, incorporating securities trading alongside the group’s existing futures and prediction markets activities.

Management said the planned platform forms part of its strategy to expand the range of financial products available to US retail customers and increase engagement across its trading services.

The acquisition would extend Plus500’s regulatory presence in the United States beyond its existing CFTC-regulated operations into the SEC-regulated securities market.

Hedge’s existing brokerage infrastructure and experience in equities and ETF trading are expected to support the development of the new service, while Plus500 plans to provide the underlying technology and platform integration.

The group operates proprietary trading systems across several international markets and intends to apply these capabilities to its expanded US operations.

Plus500 said the acquisition and planned platform launch are designed to broaden its addressable customer market and create additional opportunities to generate revenue from a wider range of financial products.

The New York office will provide an additional operational base as the company develops its US securities offering and prepares for the proposed 2027 launch.

Completion of the Hedge acquisition remains subject to the conditions attached to the agreement. The planned trading platform launch is also dependent on the completion of the transaction and the company’s subsequent integration and development activities.

About Plus500

Plus500 is a London-listed financial technology group that develops and operates proprietary online trading platforms for retail and institutional customers.

The company provides access to a range of financial instruments, including over-the-counter contracts for difference (CFDs), share dealing, futures and options on futures.

Its platforms cover more than 2,500 underlying instruments across asset classes including equities, stock indices, commodities, exchange-traded funds, foreign exchange and cryptocurrencies.

Plus500 operates in more than 60 countries and holds regulatory licences in several jurisdictions, including the United Kingdom, United States, Australia and Japan.

The group’s trading platforms are available through web browsers and applications for iOS, Android and Windows devices.

Plus500 has been listed on the London Stock Exchange since 2013 and is a constituent of the FTSE 250 and STOXX Europe 600 indices.

The company continues to develop its multi-asset trading operations, including its US futures business and planned expansion into SEC-regulated securities brokerage services.

Abingdon Health (LSE:ABDX) reported a 32% increase in total revenue to £11.3 million for the financial year ended 2026, supported by growth in contract development activities and regulatory consulting services.

The medical technology contract services provider recorded a 30% increase in reported revenue to £11.0 million, while gross margin improved to 47.1%. Contract development income rose 56% during the year, contributing to the group’s overall revenue growth.

Abingdon achieved positive adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) in the second half of FY26, while its annual pre-tax loss narrowed to £2.0 million.

The company ended the financial year with cash balances of £2.9 million, following investment in its operational capabilities and international expansion.

Contract development activities accounted for a significant proportion of the group’s revenue growth, reflecting demand for its diagnostic test development and manufacturing services.

Abingdon provides contract development and manufacturing organisation (CDMO) services for lateral flow and other in vitro diagnostic products, supporting customers through product development, testing, regulatory processes and commercial manufacturing.

Revenue from regulatory and medical technology consulting services increased 21% to £4.1 million during FY26. These activities include regulatory compliance, quality management, technical documentation and performance evaluation services for diagnostic product developers.

The group also completed a £3.2 million equity fundraising during the year to provide additional working capital and support the expansion of its US operations.

Part of the funding is being allocated to the company’s facility in Madison, Wisconsin, which Abingdon intends to develop into a manufacturing and performance evaluation centre.

The expansion is designed to increase the services available to US customers, adding manufacturing capabilities to the group’s existing development, testing and regulatory support operations.

Abingdon also expanded its presence in the US capital markets, with its shares beginning trading on the OTCQB market under the ticker ABDXF. The company retains its existing London Stock Exchange listing under LSE:ABDX.

Management reported a pipeline of contract development projects, including programmes expected to progress towards manufacturing activities as customers advance their diagnostic products through development and regulatory stages.

However, the company said delays affecting certain programmes are expected to influence the timing of revenue recognition during FY27.

As a result, management anticipates that revenue for the current financial year will be substantially weighted towards the second half, reflecting the expected timing of project delivery and commercial manufacturing activities.

The company continues to invest in its development, manufacturing and regulatory service capabilities across its UK and US operations.

Abingdon’s FY26 results included higher revenue, an improvement in gross margin and a reduction in the annual pre-tax loss, alongside the achievement of positive adjusted EBITDA during the second half.

The group enters FY27 with its expanded US operations under development and a pipeline of customer programmes, although the timing of contract progression and associated revenue remains dependent on project schedules.

About Abingdon Health PLC

Abingdon Health plc is a UK-headquartered medical technology contract services company specialising in rapid diagnostic testing and in vitro diagnostics.

The group provides contract development and manufacturing services for lateral flow assays, alongside regulatory consulting, analytical testing, quality management and diagnostic product performance evaluation.

Its operations are based in York and Doncaster in England and Madison, Wisconsin, in the United States, serving customers across healthcare, biotechnology, animal health and environmental testing markets.

Abingdon supports diagnostic product developers through multiple stages of commercialisation, including initial product design, assay development, validation, regulatory documentation, manufacturing scale-up and routine production.

The group’s subsidiaries include Compliance Solutions (Life Sciences), IVDeology and Abingdon Analytical, which provide services covering regulatory strategy, quality management systems, technical file preparation, auditing, training and analytical evaluation.

Through its development, manufacturing and consulting operations, Abingdon works with customers seeking regulatory approval and commercial production of diagnostic products in the UK, European Union, United States and other international markets.

Arkle Resources PLC (LSE:ARK) has reported uranium mineralisation across eight of nine reconnaissance reverse circulation (RC) drill holes at its primary uraniferous leucogranite (ULG) target on exploration licence EPL 8995 in Namibia’s Erongo region.

The company said the drilling identified uranium grades exceeding 100 parts per million (ppm) U₃O₈ across an area measuring approximately 1.4 kilometres by 0.6 kilometres, providing initial information on the extent of mineralisation at the prospect.

The results form part of Arkle’s exploration programme targeting uranium deposits associated with leucogranite formations, a geological setting also found at several established uranium projects in Namibia.

According to the company, eight of the nine reconnaissance holes intersected mineralisation above 100 ppm U₃O₈, with several drill holes ending within mineralised material. This indicates that the full depth extent of the identified mineralisation has not yet been established.

Drill hole R069 returned the most extensive mineralisation reported in the programme, with uranium present from surface to the end of the hole. The company identified multiple mineralised intervals, including thicker sections and higher-grade zones exceeding 200 ppm U₃O₈.

Arkle said the mineralisation includes uranium-bearing sheets within the leucogranite system. Further drilling will be required to determine their continuity, geometry and distribution across the target area.

The company compared the uranium grades encountered at the ULG prospect with those reported at regional deposits, including Etango, Norasa and Omahola. These projects provide geological reference points for Arkle’s ongoing assessment of the Erongo licence area.

Arkle is investigating the potential for a bulk-tonnage uranium deposit that could be suitable for open-pit extraction. However, the current reconnaissance results do not establish a mineral resource, and additional exploration will be necessary to assess the deposit’s size and characteristics.

A follow-up drilling programme is scheduled to begin in November, subject to contractor availability. The company said the programme is fully funded and will focus on testing mineralisation at greater depths, reducing drill spacing and examining lateral extensions beyond the areas already investigated.

The planned work is intended to provide further information on the continuity of uranium-bearing zones and support the geological interpretation of the ULG system.

Alongside drilling at the primary target on EPL 8995, Arkle intends to undertake systematic exploration of additional leucogranite targets within its Namibian licence portfolio.

The company also holds exploration interests on EPL 8290, where further targets form part of its broader uranium exploration activities in the Erongo region.

Arkle’s exploration strategy includes geological mapping, geophysical surveys, geochemical sampling, trenching and drilling to identify and evaluate prospective uranium-bearing formations.

The company is investigating both primary leucogranite-hosted uranium mineralisation and near-surface calcrete deposits, allowing it to assess different geological styles across its licence areas.

Arkle said the next phase of exploration is intended to advance the project towards an initial mineral resource estimate. The timing and scope of any future resource assessment will depend on the results of additional drilling and geological evaluation.

The November programme will provide further data on the depth and lateral extent of the mineralisation identified during the reconnaissance campaign.

About Arkle Resources PLC

Arkle Resources PLC is a London-listed mineral exploration company focused on identifying and evaluating uranium deposits in Namibia.

Its Erongo uranium project includes exploration licences targeting uranium mineralisation associated with leucogranite formations and near-surface calcrete deposits.

The company’s licence portfolio includes EPL 8995 and EPL 8290, where exploration activities are directed towards identifying uranium-bearing geological structures and assessing their potential for further development.

The Erongo region hosts several established uranium projects, including Trekkopje, Norasa and Omahola, which provide regional geological context for Arkle’s exploration activities.

Arkle’s work programmes combine geological mapping, geochemical analysis, geophysical investigations and drilling to evaluate prospective mineralised areas.

The company aims to progress selected targets through further exploration and towards the definition of mineral resources, subject to the results of ongoing technical work.

Bytes Technology Group (LSE:BYIT) reported an 18.7% increase in revenue for the six months ended 31 August 2026, alongside growth in gross profit and gross invoiced income, as the software and IT services provider expanded its activities across public and private sector markets.

Gross invoiced income increased 19.6% compared with the corresponding period last year, while gross profit rose 17.8%. The company reported growth across its software, services and hardware operations, with public sector gross profit increasing 23.1% and private sector gross profit rising 14.6%.

Earnings per share increased 6.1% during the period, while the interim dividend was raised by 3.1%.

Bytes said its sector-focused sales structure contributed to performance across both customer segments. The group operates through its Bytes and Phoenix businesses, which primarily serve private and public sector customers, respectively.

Existing customers accounted for more than 98% of gross profit during the first half, with the company reporting a renewal rate of 115.7%. The figure reflects continued business from established customer relationships, including additional spending within the existing customer base.

Services income increased 41%, supported by demand for managed services and cyber security offerings. The company has been expanding its technical delivery capabilities to support customers requiring software management, security and infrastructure services.

Average gross profit per employee rose 13% compared with the prior-year period. Bytes attributed the increase partly to the contribution from employees recruited in earlier periods, as the group continued developing its sales and technical operations.

Following the reporting period, Bytes agreed to acquire CyberOne, a provider of managed cyber security services. The proposed transaction will add round-the-clock security monitoring and management capabilities to the group’s existing service portfolio.

The company expects the acquisition to contribute positively to earnings in FY28, although financial terms of the agreement were not included in the supplied update.

Bytes also reiterated its upgraded full-year guidance, citing demand across software, artificial intelligence, cyber security and IT infrastructure.

Management expects changes to Microsoft’s partner incentive arrangements to have a positive impact on the business. The group maintains commercial relationships with major technology providers, including Microsoft, through its software licensing and services operations.

The company reported a cash balance of £68 million at the end of the first half, following £41 million of shareholder returns, including the completion of a £25 million share buyback programme.

Cash conversion during the period was consistent with the group’s usual seasonal pattern, under which a greater proportion of cash generation occurs in the second half of the financial year.

Bytes also identified approximately £4.5 million of expected full-year cost normalisation associated with employee bonuses and share-based payments returning to typical levels. These costs form part of the group’s financial outlook for the remainder of the year.

The company continues to develop its sector-focused sales operations and technical service capabilities, including the use of artificial intelligence tools within internal processes.

With the proposed CyberOne acquisition and its existing managed services activities, Bytes plans to expand its cyber security offering while maintaining its software licensing, cloud and infrastructure operations.

About Bytes Technology Group

Bytes Technology Group Plc is a UK-listed provider of software, cloud, artificial intelligence, cyber security and IT infrastructure solutions, serving organisations across the United Kingdom and Ireland.

The group operates through two principal businesses, Bytes and Phoenix, which provide software licensing, technology procurement, managed services and related technical support to private and public sector customers.

Its services include software asset management, cloud infrastructure, cyber security and technology consultancy, with Microsoft technologies representing an important part of its commercial offering.

Bytes has been developing its sector-specific sales structure, expanding technical delivery resources and introducing artificial intelligence tools into internal operations to support sales and service delivery.

The group works with established technology vendors and provides licensing and managed services to organisations with ongoing software, infrastructure and security requirements.

Oxford Instruments (LSE:OXIG) reported an increase of nearly 44% in group order intake during the first half of its financial year, alongside revenue growth of approximately 8% and an improvement of more than 100 basis points in adjusted operating margin.

The FTSE 250 scientific technology company also reported net cash of £75 million, supported by improved cash conversion and working capital management. Management said its order book provides substantial coverage for the second half and maintained confidence in meeting full-year market expectations.

The Advanced Technologies division recorded order growth of more than 125%, supported by contracts associated with volume manufacturing for data communications applications. The division’s order book now extends into the 2028 financial year and covers its expected revenue for FY27.

Revenue in Advanced Technologies increased by approximately 26% during the first half as Oxford Instruments expanded production capacity and supply chain operations to accommodate customer demand. Adjusted operating margins also increased despite additional investment in the division.

The Imaging and Analysis division reported double-digit growth in order intake, with demand from semiconductor and materials science customers contributing to the increase.

Revenue in the division rose by approximately 2% to 3%, reflecting a more moderate rate of growth than orders. The company said smaller product lines continued rebuilding their order books following a period of higher activity in the preceding quarter.

Adjusted operating margins in Imaging and Analysis improved compared with the corresponding period last year. Oxford Instruments is continuing to invest in customer-facing capabilities and operational risk management as part of its divisional development plans.

At group level, free cash flow increased compared with the prior-year period. The improvement reflected changes in working capital management, reduced adjusting items and the elimination of pension contributions.

Oxford Instruments also provided an update on its £100 million share buyback programme. By the end of September, the company had completed £83 million of repurchases and expects to conclude the remaining programme early in the new year.

Management attributed the first-half performance to progress in implementing its strategy and increased customer demand for its process and platform technologies.

The company said its operational priorities include expanding manufacturing capacity, developing supply chain arrangements and improving its service capabilities to support existing and future orders.

Oxford Instruments continues to serve customers in semiconductor manufacturing, materials analysis and data communications, with the Advanced Technologies division’s order book providing visibility into future financial periods.

The company maintained its expectation of meeting full-year market forecasts, supported by its existing order book and planned operational expansion.

About Oxford Instruments

Oxford Instruments is a UK-based scientific technology company listed on the London Stock Exchange and included in the FTSE 250 index.

Founded in 1959 as a technology spin-out from the University of Oxford, the company develops and supplies scientific instruments, analytical systems and associated technologies to academic institutions, research organisations and industrial customers.

Its operations include Imaging and Analysis and Advanced Technologies, serving applications in semiconductor manufacturing, materials science, healthcare, life sciences and data communications.

The company focuses on developing scientific instrumentation and manufacturing technologies for research and industrial applications, alongside investment in production capacity and international customer support.